Samer Suki is an expert in the field of Hematology. He received awards:"Meaningful Use Stage 1 Certification" and "Whos Who in Medicine and Healthcare". Samer S. Suki is also published. He has 5 publications published. The lastest publication: "Risk classification for large cell lymphoma using lactate dehydrogenase, beta-2 microglobulin, and thymidine kinase.' Samer S. Suki is registered with Medicare and accepts Medicare payments.
NPI NUMBER | 1639132962 | |
NPPES Provider LastName | SUKI | |
NPPES Provider FirstName | SAMER | |
NPPES Provider ZIPCode | 773396008 | |
NPPES Provider State | TX | |
Specialty Description | Hematology/Oncology | |
Total Claim Count | 1340.0 | |
Distinct Opioid Count | 6.0 | |
Opioid Claim Count | 196.0 | |
Percent Opioid Claims | 14.63 |
National Provider Identifier [NPI] | 1639132962 |
Last Name Of The Provider | SUKI |
First Name Of The Provider | SAMER |
View All |
![]() |
Dr. Elham Abbasi-Hafshejani, MD
![]() |
![]() |
Dr. Mary K. Crow, MD
![]() |
![]() |
Dr. David P. Ellent, MD
![]() |
![]() |
Dr. Anirudha Dasgupta, MD
![]() |
![]() |
Dr. Antoine N. Finianos, MD
![]() |